Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 44, Issue SUPPL. 3, 2003, Pages

  Maloney, David G ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Allogeneic stem cell transplantation; Graft vs. host disease; Graft vs. lymphoma effect; Graft vs. tumor effect; Non Hodgkin's lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PACLITAXEL; RITUXIMAB; TACROLIMUS; VINCRISTINE;

ACUTE GRAFT REJECTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CONTROL; CANCER GRADING; CANCER RECURRENCE; CANCER RISK; CELL SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE ACTIVITY; DRUG POTENTIATION; FOLLICULAR LYMPHOMA; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; GRAFT VERSUS LYMPHOMA EFFECT; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LARGE CELL LYMPHOMA; LYMPHATIC LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MORTALITY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK REDUCTION; SIDE EFFECT; T LYMPHOCYTE; TREATMENT INDICATION; WHOLE BODY RADIATION;

GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 1042291997     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001623694     Document Type: Article

References (25)

1. Branson, K., Chopra, R., Kottaridis, P.D., McQuaker, G., Parker, A., Schey, S., et al. (2002) "Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies", Journal of Clinical Oncology, 20, 4022-4031.
2. Chapuis, B., Schmitz, N., Horowitz, M.M., Gale, R.P., Goldman, J.M., Loberiza, F.R. Jr, et al. (2000) "Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation". IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT), Blood, 95, 3702-3709.
3. van Besien, K.W., de Lima, M., Giralt, S.A., Moore, D.F. Jr, Khouri, I.F., Rondon, G., et al. (1997) "Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect", Bone Marrow Transplantation, 19, 977-982.
4. Or, R., Ackerstein, A., Nagler, A., Amar, A., Naparstek, E., Varadi, G., et al. (1998) "Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation", Journal of Immunotherapy, 21, 447-453.
5. Bellucci, R., Alyea, E.P., Weller, E., Chillemi, A., Hochberg, E., Wu, C.J., et al. (2002) "Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma", Blood, 99, 4610-4617.
6. International Bone Marrow Transplant Registry/Autologous Blood and Bone Marrow Transplant Registry. (2002) IBMTR/ABMTR Newsletter 9, 12.
7. Freedman, A.S., Neuberg, D., Mauch, P., Soiffer, R.J., Anderson, K.C., Fisher, D.C., et al. (1999) "Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma", Blood, 94, 3325-3333.
8. Colombat, P., Cornillet, P., Deconinck, E., Tourani, J.M., Gardembas, M., Delain, M., et al. (2000) "Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study", Bone Marrow Transplantation, 26, 971-977.
9. Schouten, H.C., Kvaloy, S., Sydes, M., Qian, W. and Fayers, P.M. (2000) "The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL)", Annals of Oncology, 11(Suppl. 1), 91-94.
10. van Besien, K., Sobocinski, K.A., Rowlings, P.A., Murphy, S.C., Armitage, J.O., Bishop, M.R., et al. (1998) "Allogeneic bone marrow transplantation for low-grade lymphoma", Blood, 92, 1832-1836.
11. Hosing, C. and Champlin, R.E. (2002) "The choice of allogeneic or autologous hematopoietic transplantation for NHL", Cytotherapy, 4, 259-269.
12. McSweeney, P.A., Niederwieser, D., Shizuru, J., Sandmaier, B.M., Molina, A.J., Maloney, D.G., et al. (2001) "Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects", Blood, 97, 3390-3400.
13. Toze, C.L., Shepherd, J.D., Connors, J.M., Voss, N.J., Gascoyne, R.D., Hogge, D.E., et al. (2000) "Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia", Bone Marrow Transplantation, 25, 605-612.
14. Corradini, P., Voena, C., Tarella, C., Astolfi, M., Ladetto, M., Palumbo, A., et al. (1999) "Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells", Journal of Clinical Oncology, 17, 208-215.
15. Martinelli, G., Terragna, C., Zamagni, E., Ronconi, S., Tosi, P., Lemoli, R.M., et al. (2000) "Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma", Journal of Clinical Oncology, 18, 2273-2281.
16. Gahrton, G., Svensson, H., Cavo, M., Apperly, J., Bacigalupo, A., Bjorkstrand, B., et al. European Group for Blood and Marrow Transplantation. (2001) "Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres", British Journal of Haematology, 113, 209-216.
17. Maloney, D.G., Sandmaier, B.M., Mackinnon, S. and Shizuru, J.A. (2002) "Non-myeloablative transplantation", Hematology, (Am Soc Hematol Educ Program), 392-421.
18. Maris, M.B., Niederwieser, D., Sandmaier, B., et al. (2002) "Engraftment of nonmyeloablative hematopoietic stem cell transplants (HSCT) using marrow and PBSC from 10/10 HLA antigen matched unrelated donors (URDSs) for patients ineligible for conventional HSCT", Biology of Blood Marrow Transplantation, 8, 63 [abstract].
19. Khouri, I.F., Saliba, R.M., Giralt, S.A., Lee, M.S., Okoroji, G.J., Hagemeister, F.B., et al. (2001) "Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality", Blood, 98, 3595-3599.
20. Khouri, I.F., Keating, M., Korbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., et al. (1998) "Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies", Journal of Clinical Oncology, 16, 2817-2824.
21. Gandhi, V., Kemena, A., Keating, M.J. and Plunkett, W. (1993) "Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy", Leukemia and Lymphoma, 10, 49-56.
22. Czuczman, M.S., Grillo-Lopez, A.J., White, C.A., Saleh, M., Gordon, L., LoBuglio, A.F., et al. (1999) "Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy", Journal of Clinical Oncology, 17, 268-276.
23. Gupta, D., Bybee, A., Cooke, F., Giles, C., Davis, J.G., McDonald, C., et al. (1999) "CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome", British Journal of Haematology, 104, 166-167.
24. Holmberg, L.A., Boeckh, M., Hooper, H., Leisenring, W., Rowley, S., Heimfeld, S., et al. (1999) "Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation", Blood, 94, 4029-4035.
25. Stewart, A.K., Vescio, R., Schiller, G., Ballester, O., Noga, S., Rugo, H., et al. (2001) "Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial", Journal of Clinical Oncology, 19, 3771-2779.